US 11426467
Dosage regimes for the administration of an anti-CD25 ADC
granted A61KA61K2039/545A61K31/5517
Quick answer
US patent 11426467 (Dosage regimes for the administration of an anti-CD25 ADC) held by ADC THERAPEUTICS SA expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADC THERAPEUTICS SA
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/545, A61K31/5517, A61K39/3955, A61K45/06